Study explores whether certain brain proteins may play a role in Alzheimer’s development

Mer­ck post­ed yet an­oth­er strong quar­ter on the back of its can­cer ther­a­py Keytru­da, in what’s be­com­ing al­most a rou­tine event for the New Jer­sey

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in patients with diabetes and metabolic dysfunction-associated steatotic